A Phase II Study Of Perifosine In Patients With Recurrent Or Metastatic Head And Neck Cancer.
Latest Information Update: 06 Mar 2013
At a glance
- Drugs Perifosine (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
- 01 Mar 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Apr 2009 Actual end date Jan 2007 added as reported by ClinicalTrials.gov.